Predictive value of thyroid-stimulating hormone in postmenopausal type 2 diabetes mellitus patients with normal thyroid function associated with ultrasound-diagnosed non-alcoholic fatty liver disease. Issue 1 (31st December 2022)
- Record Type:
- Journal Article
- Title:
- Predictive value of thyroid-stimulating hormone in postmenopausal type 2 diabetes mellitus patients with normal thyroid function associated with ultrasound-diagnosed non-alcoholic fatty liver disease. Issue 1 (31st December 2022)
- Main Title:
- Predictive value of thyroid-stimulating hormone in postmenopausal type 2 diabetes mellitus patients with normal thyroid function associated with ultrasound-diagnosed non-alcoholic fatty liver disease
- Authors:
- Du, Yijun
Pan, Tianrong
Zhong, Xing
Liu, Nina
Zhang, Qiu - Abstract:
- Abstract : We aimed to determine the role of thyroid-stimulating hormone (TSH) of postmenopausal type 2 diabetes mellitus (T2DM) women with normal thyroid function in identifying ultrasound-diagnosed nonalcoholic fatty liver disease (NAFLD). The association between ultrasound-diagnosed NAFLD and biochemical parameters of 376 patients was analyzed among overall patients and in different age groups (≤60 years; 60–70 years; >70 years). The receiver operating characteristic curve (ROC) was used to analyze the diagnostic ability of TSH for ultrasound-diagnosed NAFLD. The prevalence of ultrasound-diagnosed NAFLD in postmenopausal T2DM women was 44.1%. Multivariate logistic regression analysis showed that the levels of BMI (OR = 0 .843, 95%CI: 0.779–0.913), HbA1c (OR = 0 .836, 95%CI: 0.738–0.946), TG (OR = 0 .539, 95%CI: 0.408–0.712), ALT (OR = 0 .979, 95%CI: 0.962–0.995) were independent risk factors of NAFLD. BMI and TG were related to the NFALD risk of patients in the three age groups. HOMA-IR and HbA1c were independent risk factors of NAFLD among patients aged ≤60 years and 60–70 years, respectively. The TSH with the best diagnostic ability was among ≤60 years old patients (sensitivity = 0.486; specificity = 0.730). Higher BMI, abnormal glucose and lipid metabolism had a higher risk for developing NFALD, and TSH diagnosis is more meaningful in relatively young patients.
- Is Part Of:
- All life. Volume 15:Issue 1(2022)
- Journal:
- All life
- Issue:
- Volume 15:Issue 1(2022)
- Issue Display:
- Volume 15, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 15
- Issue:
- 1
- Issue Sort Value:
- 2022-0015-0001-0000
- Page Start:
- 211
- Page End:
- 219
- Publication Date:
- 2022-12-31
- Subjects:
- Type 2 diabetes mellitus -- non-alcoholic fatty liver disease -- thyroid-stimulating hormone
Life sciences -- Periodicals
Biology -- Periodicals
Electronic journals
Periodicals
570.5 - Journal URLs:
- https://www.tandfonline.com/toc/tfls21/current ↗
- DOI:
- 10.1080/26895293.2022.2035827 ↗
- Languages:
- English
- ISSNs:
- 2689-5293
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 21205.xml